atai Life Sciences Advances Phase 1/2a Psilocin Trial for Depression
ELE-101, a novel intravenous (IV) formulation of psilocin, is being developed by atai Life Sciences to offer a rapid, reliable,... Lire la suite
June 22, 2024
Recently Published Articles
Rejuveron Secures $75M for Aging Solutions and Middle East Expansion
Rejuveron Life Sciences AG, a leader in biotechnology focused on aging therapies, has successfully secured USD $75 million in a... Lire la suite
June 4, 2024
WEFOX AND WIND TRE SELECT HDI EMBEDDED AS THEIR INSURANCE PARTNER
wefox and Wind Tre have announced a strategic partnership with HDI Embedded to provide extended warranty insurance for household appliances... Lire la suite
June 3, 2024
WEFOX APPOINTS DOMINIK ULRICH AS CHIEF RISK OFFICER
wefox, a leading global insurtech company, has announced the appointment of Dominik Ulrich as its new Chief Risk Officer (CRO).... Lire la suite
June 3, 2024
Most Popular Articles
Discover how GrubMarket’s acquisition of Parsemony enhances its software solutions for the food supply chain, integrating cutting-edge AI and comprehensive services to transform the industry. Explore the expanded capabilities and benefits for fresh produce distributors and wholesalers.
Food
June 23, 2024
